Navigation Links
Inoculation of Viral RNA and cDNA to Potato and Tobacco Plants Using the Helios Gene Gun

The pressure of 200 psi and the distance of 0 cm were optimal for A6, differing significantly (p< 0.01) from the other pressures used. The higher pressures of 250 and 300 psi ripped the leaves and are thus not recommended for use. Although bombardment at a 2 cm distance from the target tissue resulted in spreading of the micro carriers (and subsequently the necrotic lesions) over a larger area on the leaf, the total number of necrotic lesions was no greater than after bombardment at a distance of 0 cm. No differences were observed between bombardment using PVA RNA or cDNA (data not shown).

PVP Concentration and Micro c a rrier Size. PVP serves as an adhesive during the coating of DNA/(or RNA)/micro carrier suspension to the walls of the Goldcoat tubing. With both DNA and RNA of PVA, the optimal concentration was shown to be 0.05 mg PVP/ml 99.5% ethanol. This resulted in significantly more lesions (p< 0.01) in A6 leaves than at PVP concentrations of 0 or 0.1 mg/ml (Figure 5).

Three sizes of micro carriers were used: 0.6, 1.0 and 1.6 m. The 0.6 m carriers were significantly more efficient in initiation of infection (p< 0.01) than the other two sizes used (Figure 6).

Ratios of Microcarrier and DNA Amounts. Various ratios of microcarriers and viral cDNA (Table 1) were tested by bombarding A6 leaves. The numbers of infection sites observed with different ratios of microcarriers and DNA were not significantly different statistically. As little as 0.1 g viral cDNA per bombardment was sufficient to trigger development of necrotic lesions in A6.


Discussion
The Helios gene gun is being used in several laboratories f
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System
2. Versatile Reporter Vectors for Monitoring Viral Transduction
3. Maximize Viral RNA Yield from Biological Fluid
4. Total RNA Isolation: 100 l Viral Sample From Cultured-Cell Supernatant Containing Virus
5. Isolation and Characterization of Anti-Viral Nucleoside Compounds from the Chinese Herb Taraxacum Mongolicum
6. A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF
7. A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF
8. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
9. Oil-Free PCR Using the Hot Top Assembly
10. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
11. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
Post Your Comments:
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3